MedPath

Cardio-ankle Vascular Index (CAVI) in Hypertension Patients After One Year of Treatment

Completed
Conditions
Hypertension
Registration Number
NCT03680313
Lead Sponsor
Hanoi Medical University
Brief Summary

This study aimed to evaluate the role of the cardio-ankle vascular index (CAVI) in evaluating arterial stiffness changes, the degree of atherosclerosis in patients with hypertension after 1 year of treatment and analysis the correlation between CAVI and cardiovascular risk factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • Patients have never been diagnosed with hypertension.
  • Patients have been diagnosed with primary hypertension, but not take any treatment
Exclusion Criteria
  • Cases with non-primary hypertension or suffering from cardiovascular complications such as myocardial infarction, cerebral stroke, vascular disease, severe heart failure (EF<1) in the time of measurement.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CAVI score in hypertension group after one year of treatment1 year

CAVI score of patients who achieved their target blood pressure after one year of hypertension treatment

Secondary Outcome Measures
NameTimeMethod
Correlation between CAVI and dislypidemia status1 year

Evaluating correlation between CAVI score and dyslipidemia status in hypertension patients

Correlation between CAVI and smoking status1 year

Evaluating correlation between CAVI score and smoking status in hypertension patients

Correlation between CAVI and overweight status1 year

Evaluating correlation between CAVI score and overweight status in hypertension patients

Correlation between CAVI and diabetes status1 year

Evaluating correlation between CAVI score and diabetes status in hypertension patients

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.